New Report Calls for Reform of the Intellectual Property System
The intellectual property (IP) system in the US must be transformed if it is to foster biotechnological advances, national and international IP and biotech leaders said today.
Read MorePosted by Clinical Lab Products | Oct 15, 2008 | Cancer, Miscellaneous |
The intellectual property (IP) system in the US must be transformed if it is to foster biotechnological advances, national and international IP and biotech leaders said today.
Read MorePosted by Clinical Lab Products | Oct 13, 2008 | Cancer, Miscellaneous, Osteoporosis |
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Childrens Center.
Read MorePosted by Clinical Lab Products | Oct 1, 2008 | Molecular Diagnostics |
PCR-based assays deliver speed and accuracy, and see increasing adoption in the clinical lab.
Read MorePosted by Clinical Lab Products | Sep 18, 2008 | Sexually Transmitted Diseases |
A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.
Read MorePosted by Clinical Lab Products | Sep 16, 2008 | Miscellaneous |
Complex viral genetics and overlapping disease symptoms pose challenges
Read More